HK이노엔

195940KOSDAQ의약품 제조업

50.6 / 100

Reference Date: 2026-06-10

Financial Score19.5 / 40

News Sentiment18.1 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE is above the industry average but ROE is below the industry average. Plunged 19.4% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

HK Inoent is a pharmaceutical company primarily engaged in ETC (Specialty Pharmaceuticals) and H&B (Health & Beauty) businesses, achieving sales of 1.632 trillion KRW and operating profit of 110.9 billion KRW in 2025 through key products like K-Cap and H&B items such as Condition. Established in 1984, the company expanded through the acquisition of Hanil Pharm in 2006 and Hanacolma in 2018, focusing on R&D and global market expansion.

Number of Employees

1,723people

Average Salary

84.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

15.38Industry Average 11.933.0Point

Higher than industry avg (caution)

PBR

0.88Industry Average 0.894.0Point

In line with industry avg

ROE

5.87Industry Average 4.014.0Point

In line with industry avg

Debt Ratio

13.25Industry Average 12.432.0Point

Higher than industry avg (caution)

Trend 2023~20256.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲13.4% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲29.8% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 5.0% (improving, 3yr)

Detailed News Sentiment

26 totalPositive 17Neutral 9Negative 0Average Sentiment Score 72.3

Positive
HK이노엔 도입 GLP-1 비만치료제, 임상서 체중 감량 효과 위고비 ...
HK이노엔의 GLP-1 비만치료제 '에크노글루타이드'가 임상에서 체중 감소 효과가 위고비 대비 35% 향상되어 긍정적인 결과를 보여주었다.
Positive
HK이노엔 도입 비만약, 세마글루타이드와 맞대결서 우위 확인
HK이노엔의 GLP-1 계열 비만약이 임상 결과를 통해 체중 감소와 허리둘레 개선에서 우수한 성과를 보여주며 시장 경쟁력을 입증했다.
Positive
동아에스티, 온코닉테라퓨틱스 '자큐보' 국내 P-CAB 판매 2위
동아시아제약의 자큐보가 국내 P-CAB 시장에서 2위를 차지하며 경쟁력을 입증했다.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 41,100Won52-week high 57,60052-week low 41,100

1-month return0.0Point

1m -19.41% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]2026-06-01
Neutral신규시설투자등2026-05-21
Neutral분기보고서 (2026.03)2026-05-14